Clorox Company (CLX) has witnessed significant activity from investment firms, including increased holdings by Vanguard and Blackhawk Capital Partners, and reduced shares by Teacher Retirement System of Texas and International Assets Investment Management. CLX's share pricing has shown mixed results, however, market specialists expect the company's recovery story to gain momentum. The company faced a
$14.15M penalty concerning
Pine Sol product contamination incident, but balanced it with the acquisition of
GOJO Industries, the maker of
Purell, potentially reshaping its earnings mix and valuation potential. Financial giants such as Deutsche Bank and Barclays adjusted CLX's valuation following the announcement of the GOJO purchase. Clorox is set to release its Q2 earnings soon, amidst cost headwinds and mixed expectations. Additionally, the company declared a regular quarterly dividend of $1.24 per share, an attractive dividend yield that makes it hard to ignore despite lingering headwinds. Meanwhile, investor responses to the company’s reaffirmed cautious outlook and weak sales remain mixed. Despite facing penalties and future uncertainties, some analysts still view Clorox as a
valuable buy, looking forward to the impacts of its strategic acquisitions on growth and valuation.
Clorox Company CLX News Analytics from Mon, 21 Jul 2025 07:00:00 GMT to Sat, 31 Jan 2026 15:37:57 GMT -
Rating 2
- Innovation -4
- Information 3
- Rumor -4
